Since previous studies demonstrated that inhibition of FASN suppresses c-Met expression in lymphoma cells26, we investigated whether the same mechanism may contribute to the suppression of liver tumor development AKT/c-Met mice when FASN is deleted. The gene discussed is AKT1; the disease is lymphoma.